Related references
Note: Only part of the references are listed.Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes et al.
CNS DRUGS (2019)
Gepants for the treatment of migraine
Andrea Negro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Therapeutic novelties in migraine: new drugs, new hope?
Thien Phu Do et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Does inflammation have a role in migraine?
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2019)
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults
Peter J. Goadsby et al.
CEPHALALGIA (2019)
CGRP, Amylin, Immunology, and Headache Medicine
Frederick R. Taylor
HEADACHE (2019)
Rimegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
L. Lionetto et al.
DRUGS OF THE FUTURE (2019)
Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling
Chi-Chung Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Philip R. Holland et al.
NEUROTHERAPEUTICS (2018)
Neurogenic inflammation and its role in migraine
Roshni Ramachandran
SEMINARS IN IMMUNOPATHOLOGY (2018)
Lasmiditan is an effective acute treatment for migraine A phase 3 randomized study
Bernice Kuca et al.
NEUROLOGY (2018)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists
Anders Hougaard et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Efficacy and safety of 1,000mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms
C. Lampl et al.
JOURNAL OF NEUROLOGY (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
